Posted in | News | Ferrous Alloys and Metals | Business | Energy

British Columbia Court Approves Salares Lithium’s Merger with Talison Lithium

Editorial Checklist Reviewed
Sep 27 2010

Related Stories

Salares Lithium Inc. (TSX VENTURE:LIT) ("Salares" or the "Company") is pleased to announce that the Company received today final approval from the Supreme Court of British Columbia regarding the previously announced plan of arrangement (the "Arrangement") to merge with Talison Lithium Limited ("Talison").

The Arrangement is subject to certain conditions, including the final approval of the TSX Venture Exchange ("TSXV"). Completion of the Arrangement and final approval from the TSXV is expected to occur on Wednesday, September 22, 2010.

The TSX has conditionally approved the listing of the Talison ordinary shares under the symbol "TLH", with trading expected to commence on the TSX at the market open on September 23, 2010.

Source:

http://www.salareslithium.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback